Income Statement for the Period, Consolidated (IFRS)
Gross Sales Revenues
10
0
CAGR
-1,9%
2Q13
9.88B
9882457
2Q14
10.4B
10442822
2Q15
10.8B
10759391
2Q16
10.2B
10248778
2Q17
9.17B
9165853
Assets, Consolidated (IFRS)
Total Assets
10
0
CAGR
-2,2%
2Q14
57.9B
57893657
2Q15
68.8B
68778447
2Q16
58.2B
58233705
2Q17
54.2B
54175125
Liabilities, Consolidated (IFRS)
Consolidated Stockholders' Equity
3
0
CAGR
-7,2%
2Q14
31.7B
31706047
2Q15
35.5B
35461935
2Q16
27.8B
27760998
2Q17
25.3B
25345777